Knittel T, Kobold D, Dudas J, Saile B, Ramadori G
Department of Internal Medicine, Section of Gastroenterology and Endocrinology, University of Göttingen, Göttingen, Germany.
Am J Pathol. 1999 Dec;155(6):1841-8. doi: 10.1016/S0002-9440(10)65502-2.
During liver tissue repair, hepatic stellate cells (HSCs), a pericyte-like nonparenchymal liver cell population, transform from a quiescent status (resting HSCs) into myofibroblast like cells (activated HSCs); the latter is the principal matrix-synthesizing cell of the liver. Although several factors have been shown to be involved in this important process, the molecular mechanisms regulating HSC activation are still under investigation. To identify key regulatory proteins involved in the HSC activation process, we used different mRNA display technologies, with cDNAs prepared from HSCs at different stages of in vitro activation. With the latter technique, the transcription factor Ets-1 was detected through its down-regulation during activation. As confirmed by Northern blot and reverse transcriptase-polymerase chain reaction (RT-PCR) analysis, mRNAs coding for Ets-1 were present in the highest amounts in freshly isolated HSCs and in HSCs 2 days after plating (classified as resting HSCs/early activated HSCs) and were diminished in HSCs 7 days after plating (activated cells). Ets-1 protein was present in HSC-lysates, as assessed by Western blot, and bound to an oligonucleotide containing the Ets-1 consensus cis-acting motif, as demonstrated by electrophoretic mobility shift assay. Ets-1 binding activity peaked in nuclear extracts prepared from resting/early activated cells and was diminished in extracts derived from fully activated cells. In contrast, binding activity of the transcription factors TFIID, AP-1, and SP-1 was highest in activated HSCs and only barely detectable in resting/early activated HSCs. By Northern blot and RT-PCR analysis, Ets-1-specific transcripts were present in parenchymal and other nonparenchymal liver cells too, illustrating that hepatic Ets-1 expression is not specific or restricted to HSCs. However, the unique pattern of Ets-1 binding activity present in resting versus activated HSCs and its known implications for cellular differentiation and tissue remodeling suggest that Ets-1 could be of crucial importance for HSC activation and hepatic tissue repair.
在肝组织修复过程中,肝星状细胞(HSCs)是一种类周细胞的非实质肝细胞群体,它从静止状态(静止HSCs)转变为成肌纤维细胞样细胞(活化HSCs);后者是肝脏主要的基质合成细胞。尽管已有多种因素被证明参与了这一重要过程,但调节HSC活化的分子机制仍在研究中。为了鉴定参与HSC活化过程的关键调节蛋白,我们使用了不同的mRNA展示技术,用体外活化不同阶段的HSCs制备cDNA。通过后一种技术,转录因子Ets-1在活化过程中因其下调而被检测到。经Northern印迹和逆转录-聚合酶链反应(RT-PCR)分析证实,编码Ets-1的mRNA在新鲜分离的HSCs和接种后2天的HSCs(归类为静止HSCs/早期活化HSCs)中含量最高,而在接种后7天的HSCs(活化细胞)中减少。通过蛋白质印迹评估,Ets-1蛋白存在于HSC裂解物中,并且通过电泳迁移率变动分析证明它与含有Ets-1共有顺式作用基序的寡核苷酸结合。Ets-1结合活性在从静止/早期活化细胞制备的核提取物中达到峰值,而在从完全活化细胞获得的提取物中降低。相反,转录因子TFIID、AP-1和SP-1的结合活性在活化HSCs中最高,而在静止/早期活化HSCs中仅勉强可检测到。通过Northern印迹和RT-PCR分析,Ets-1特异性转录本也存在于实质和其他非实质肝细胞中,说明肝脏中Ets-1的表达并非HSCs所特有或局限于HSCs。然而,静止与活化HSCs中存在的Ets-1结合活性的独特模式及其对细胞分化和组织重塑的已知影响表明,Ets-1可能对HSC活化和肝组织修复至关重要。